Transcription of Phenazepam - WHO
{{id}} {{{paragraph}}}
Phenazepam Pre-Review Report Agenda item Expert Committee on Drug Dependence Thirty-seventh Meeting Geneva, 16-20 November 2015 37th ECDD (2015) Agenda item Phenazepam Page 2 of 32 37th ECDD (2015) Agenda item Phenazepam Page 3 of 32 Contents Acknowledgements .. 5 Summary .. 6 1. Substance identification .. 7 A. International Nonproprietary Name (INN).. 7 B. Chemical Abstract Service (CAS) Registry Number .. 7 C. Other Names .. 7 D. Trade Names .. 7 E. Street Names .. 7 F. Physical properties .. 7 G. WHO Review History .. 7 2. Chemistry .. 7 A. Chemical Name .. 7 B. Chemical Structure .. 7 C. Stereoisomers .. 8 D. Synthesis .. 8 E. Chemical description .. 8 F. Chemical 8 G. Chemical identification .. 8 3. Ease of convertibility into controlled substances.
37th ECDD (2015) Agenda item 5.8 Phenazepam Page 5 of 32 Acknowledgements This report has been drafted under the responsibility of the WHO Secretariat, Essential Medicines and Health Products, Policy Access and Use team.
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}